92 related articles for article (PubMed ID: 19854303)
21. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
[TBL] [Abstract][Full Text] [Related]
22. Fabrication strategy for amphiphilic microcapsules with narrow size distribution by premix membrane emulsification.
Wei Y; Wang Y; Wang L; Hao D; Ma G
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):399-408. PubMed ID: 21683559
[TBL] [Abstract][Full Text] [Related]
23. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ
Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778
[TBL] [Abstract][Full Text] [Related]
24. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
25. Preparation of protein loaded poly(D,L-lactide-co-glycolide) microparticles for the antigen delivery to dendritic cells using a static micromixer.
Wischke C; Lorenzen D; Zimmermann J; Borchert HH
Eur J Pharm Biopharm; 2006 Apr; 62(3):247-53. PubMed ID: 16288857
[TBL] [Abstract][Full Text] [Related]
26. Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation.
Maquet V; Boccaccini AR; Pravata L; Notingher I; Jérôme R
Biomaterials; 2004 Aug; 25(18):4185-94. PubMed ID: 15046908
[TBL] [Abstract][Full Text] [Related]
27. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment.
Siepmann J; Elkharraz K; Siepmann F; Klose D
Biomacromolecules; 2005; 6(4):2312-9. PubMed ID: 16004477
[TBL] [Abstract][Full Text] [Related]
28. The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs.
Bile J; Bolzinger MA; Vigne C; Boyron O; Valour JP; Fessi H; Chevalier Y
Int J Pharm; 2015 Oct; 494(1):152-66. PubMed ID: 26235922
[TBL] [Abstract][Full Text] [Related]
29. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
Hedberg EL; Shih CK; Lemoine JJ; Timmer MD; Liebschner MA; Jansen JA; Mikos AG
Biomaterials; 2005 Jun; 26(16):3215-25. PubMed ID: 15603816
[TBL] [Abstract][Full Text] [Related]
30. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
31. Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.
Patomchaiviwat V; Paeratakul O; Kulvanich P
AAPS PharmSciTech; 2008; 9(4):1119-29. PubMed ID: 18989787
[TBL] [Abstract][Full Text] [Related]
32. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
Yang Y; Gao Y; Mei X
Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
[TBL] [Abstract][Full Text] [Related]
33. The encapsulation of a model protein in poly (D, L lactide-co-glycolide) microparticles of various sizes: an evaluation of process reproducibility.
McGee JP; Singh M; Li XM; Qiu H; O'Hagan DT
J Microencapsul; 1997; 14(2):197-210. PubMed ID: 9132471
[TBL] [Abstract][Full Text] [Related]
34. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
Pavanetto F; Genta I; Giunchedi P; Conti B
J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
[TBL] [Abstract][Full Text] [Related]
36. Pore formation and pore closure in poly(D,L-lactide-co-glycolide) films.
Fredenberg S; Wahlgren M; Reslow M; Axelsson A
J Control Release; 2011 Mar; 150(2):142-9. PubMed ID: 21094192
[TBL] [Abstract][Full Text] [Related]
37. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour.
Unger F; Wittmar M; Morell F; Kissel T
Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641
[TBL] [Abstract][Full Text] [Related]
38. Poly (lactic-co-glycolic acid) particles prepared by microfluidics and conventional methods. Modulated particle size and rheology.
Perez A; Hernández R; Velasco D; Voicu D; Mijangos C
J Colloid Interface Sci; 2015 Mar; 441():90-7. PubMed ID: 25490568
[TBL] [Abstract][Full Text] [Related]
39. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
40. Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.
Cocks E; Alpar O; Somavarapu S; Greenleaf D
Drug Dev Ind Pharm; 2015 Mar; 41(3):522-8. PubMed ID: 24650006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
